Poland· PL-100214117
Carbo Medicinalis MF
A medicinal charcoal product containing carbo activatus, registered in Poland by Milapharm Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Medicinal charcoal is registered in 12 of 19 countries.
Countries holding a registration under ATC A07BA01 (medicinal charcoal), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Medicinal charcoal · ATC A07BA01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Carbo activatus
- Manufacturer
- Milapharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A07BA01
- ATC class
- Medicinal charcoal
- Defined daily dose
- 5 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990722037
- gtin05909990722044
- gtin05909990722051
- gtin05909990722068
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
85 interactions on record for medicinal charcoal.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Medicinal charcoal · interactions on record
85 records
- 1 severe
- 82 moderate
- 2 minor
Most severe, free to view
- Mycophenolic acidL04AA06severe
- NizatidineA02BA04moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Medicinal charcoal in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayKohle hevertHevert Arzneimittel
- FinlandCarbo MedicinalisOrifarm Healthcare A/S
- United StatesACTIDOSEPadagis US LLC
- BelgiumCarbo Vegetabilis Boiron 15CHBoiron
- CanadaACTIVATED CHARCOALJAMP PHARMA CORPORATION
- United KingdomActidose-Aqua Advance 1.04g/5ml oral suspensionAlliance Pharmaceuticals Ltd
- FranceACTICARBINE 70 mg, comprimé enrobéELERTE
- Japan球形吸着炭日医工
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Iceland · Kolsuspension
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2e520fca-06ca-4927-b741-6880c84a78d0 GET /v1/drugs/2e520fca-06ca-4927-b741-6880c84a78d0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "250 mg",
"packaging": "05909990722037 ¦ OTC ¦ 52422\n20 tabl.\n05909990722044 ¦ OTC ¦ 52423\n40 tabl.\n05909990722051 ¦ OTC ¦ 52424\n75 tabl.\n05909990722068 ¦ OTC ¦ 52425\n100 tabl.",
"substance": "Carbo activatus 250 mg",
"common_name": "Carbo activatus",
"pl_product_id": "100214117",
"pozwolenie_nr": "15785",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about medicinal charcoal.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.